Foeller E, Feldman DE (2004)
Hives may be its first visible sign, but the defining features are systemic: throat tightness, shortness of breath or wheezing, dizziness, rapid or weak pulse, and a sudden drop in blood pressure
Quantification of research-subject hepatic glutathione S-transferases
NICE technology appraisal guidance TA875 recommends semaglutide for use within specialist weight management services, subject to specific eligibility criteria: a BMI of 35 kg/m or above, or a lower BMI threshold for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds, alongside at least one weight-related comorbidity, and as part of a specialist multidisciplinary programme
The term stable gastric pentadecapeptide reflects both the origin and the structure of BPC-157
doi: 10.1016/J.SCP.2020.100218 185 van den HeuvelD